Cell-cycle inhibition by TNP-470 in an in vivo model of hepatocarcinoma is mediated by a p53 and p21WAF1/CIP1 mechanism.
about
An orally delivered small-molecule formulation with antiangiogenic and anticancer activityTumor suppressor and hepatocellular carcinomaSuppression of autoimmune retinal inflammation by an antiangiogenic drugOxidative stress and cell damage in a model of precancerous lesions and advanced hepatocellular carcinoma in rats.Nicotinamide inhibits the early stage of carcinogen-induced hepatocarcinogenesis in mice and suppresses human hepatocellular carcinoma cell growth.
P2860
Cell-cycle inhibition by TNP-470 in an in vivo model of hepatocarcinoma is mediated by a p53 and p21WAF1/CIP1 mechanism.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Cell-cycle inhibition by TNP-4 ...... 53 and p21WAF1/CIP1 mechanism.
@en
Cell-cycle inhibition by TNP-4 ...... 53 and p21WAF1/CIP1 mechanism.
@nl
type
label
Cell-cycle inhibition by TNP-4 ...... 53 and p21WAF1/CIP1 mechanism.
@en
Cell-cycle inhibition by TNP-4 ...... 53 and p21WAF1/CIP1 mechanism.
@nl
prefLabel
Cell-cycle inhibition by TNP-4 ...... 53 and p21WAF1/CIP1 mechanism.
@en
Cell-cycle inhibition by TNP-4 ...... 53 and p21WAF1/CIP1 mechanism.
@nl
P2093
P1476
Cell-cycle inhibition by TNP-4 ...... 53 and p21WAF1/CIP1 mechanism.
@en
P2093
Jesús M Culebras
M Cristina Duran
Paquita Gonzalez
Virginia Molpeceres
P356
10.1016/J.TRSL.2006.07.004
P577
2007-01-01T00:00:00Z